FINWIRES · TerminalLIVE
FINWIRES

Generation Development's Tax-Effective Products Expected to Garner More Interest Amid Reform, Jefferies Says

By

Generation Development Group's (ASX:GDG) tax-effective products are expected to gain more interest as changes in super tax concessions approach, Jefferies said in a Monday note.

The May 2026 Australian Federal Budget is expected to abolish the 50% Capital Gains Tax Discount, to be replaced by an inflation indexing system, which is likely to improve the relative attractiveness of Generation Development's investment bond offering.

Investment bonds are taxed at up to 30% on all earnings, with no distinction between capital gain and income. Property investors are the single biggest beneficiaries of the discount, and investment bonds may become more appealing.

The investment firm assigned a buy rating on Generation Development with a price target of AU$6.35 per share.

Related Articles

Asia

Shandong Yisheng Livestock & Poultry Breeding's Broiler Chick, Pig Sales Rise in April

Shandong Yisheng Livestock & Poultry Breeding's (SHE:002458) broiler chick sales revenue jumped 55% to 219 million yuan in April, according to a Tuesday filing with the Shenzhen bourse.Sales volume grew 13 to 55.3 million broiler chicks.Its Yisheng 909 mini broiler chicks saw sales revenue of 12.8 million yuan, up 104% year over year, while its sales volume jumped 19% to 8.2 million.Breeding pig sales revenue surged 325% to 40.4 million yuan while sales volume expanded 478% to 19,521 breeding pigs.

$SHE:002458
Asia

Trendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms

Trendlines Group (SGX:42T) said its board approved a capital injection into portfolio companies Ceretrieve and Vensica Medical by controlling shareholder Librae Holdings.Shares of the agrifood and med-tech company were down over 1% in Tuesday's afternoon trade.Librae will invest around $850,000 in the units. Additionally, Trendlines will infuse a total of $550,000 to the portfolio firms, according to a Monday filing with the Singapore Exchange.The funding is aimed at supporting the ongoing operations of the portfolio companies and helping them achieve successful exits, the filing said.Ceretrieve develops neurointerventional devices, while Vensica Medical specializes in bladder-targeted therapies.

$SGX:42T
Asia

Galaxy Entertainment Revenue Rises 11% in Q1 2026

Galaxy Entertainment Group (HKG:0027) reported HK$12.4 billion in first quarter 2026 revenue, up 11% from HK$11.20 billion a year earlier, according to a Tuesday filing with the Hong Kong bourse.Revenue from the gaming business increased to HK$10.02 billion from HK$8.92 billion in the prior year. Non-gaming revenue stood at HK$1.71 billion, rising from HK$1.56 billion, while sales from construction materials fell to HK$666 million from HK$723 million, figures showed.

$HKG:0027